Settlement Structure: Claims Made
Active: OpenCase Summary:
This settlement resolves a class action against Teva Pharmaceuticals USA, Inc., its board of directors, and the investment committee of its retirement plan. The complaint alleged that these parties breached their fiduciary duties to the Teva Pharmaceuticals Retirement Savings Plan, by not keeping plan expenses down and not properly choosing and monitoring its investment options.Docket Number:
Company: Teva Pharmaceuticals USA, Inc.
Filing Deadline: January 1, 2100
Class Period: December 6, 2013 to June 28, 2019
Objection Deadline: April 12, 2021
Final Approval Hearing: May 3, 2021Proof of Purchase:
You do not have to submit a claim form.Eligibility:
You may be eligible if you participated in the Teva Pharmaceuticals Retirement Savings Plan between December 6, 2013 and June 28, 2019, including the beneficiaries of deceased participants and alternate payees of persons subject to a Qualified Domestic Relations Order during the class period.Typical Settlement Amount:
Those who have active accounts will have their Entitlement Amounts paid into their plan accounts. Former participants will receive a check.
Total Settlement Amount: $2,550,000Class Representative Proposed Incentive Fee:
Capozzi Adler PC
Case Name: Pinnell, et al, v. Teva Pharmaceuticals USA, Inc., et al.
Settlement Website: Teva Pharmaceuticals Retirement Plan Settlement Website
JND Legal Administration
Teva ERISA Settlement
c/o JND Legal Administration
PO Box 91343
Seattle, WA 98111